الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hahnemann laboratories, inc. - digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b) -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - meloxicam -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - meloxicam -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - meloxicam -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - meloxicam -

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

novartis europharm ltd - aliskiren, amlodipine - hypertension - agents acting on the renin-angiotensin system - rasilamlo is indicated for the treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled with aliskiren or amlodipine used alone.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

noden pharma dac - aliskiren, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults.rasilez hct is indicated in patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone.rasilez hct is indicated as substitution therapy in patients adequately controlled with aliskiren and hydrochlorothiazide, given concurrently, at the same dose level as in the combination.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren, amlodipine, hydrochlorothiazide - hypertension - cardiovascular system - rasitrio is indicated for the treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of aliskiren, amlodipine and hydrochlorothiazide given concurrently at the same dose level as in the combination.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults.riprazo hct is indicated in patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone.rirpozo hct is indicated as substitution therapy in patients adequately controlled with aliskiren and hydrochlorothiazide, given concurrently, at the same dose level as in the combination.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults.sprimeo hct is indicated in patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone.sprimeo hct is indicated as substitution therapy in patients adequately controlled with aliskiren and hydrochlorothiazide, given concurrently, at the same dose level as in the combination.